BLNP 005Alternative Names: BLNP-005
Latest Information Update: 04 Sep 2015
At a glance
- Originator BL-&-H
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Clinical Phase Unknown Ovarian cancer
Most Recent Events
- 04 Sep 2015 Clinical trials in Ovarian cancer in South Korea (unspecified route) before September 2015